
Data on the updated approach to the choice of two-component antihypertensive combinations for different clinical situations are presented. Advantages and indications for combination of an angiotensin converting enzyme (ACE) inhibitor and dihydropyridine calcium antagonist are considered. Data on the efficacy and safety of the combination of calcium antagonist of the third generation, lercanidipine, and ACE inhibitor, enalapril, are presented.
arterial hypertension, fixed combinations of antihypertensive drugs, лерканидипин, RM1-950, антагонисты кальция, артериальная гипертония, combined therapy, ace inhibitors, calcium antagonists, RC666-701, Diseases of the circulatory (Cardiovascular) system, эналаприл, Therapeutics. Pharmacology, фиксированные комбинации антигипертензивных препаратов, комбинированная терапия, enalapril, lercanidipine, ингибиторы АПФ
arterial hypertension, fixed combinations of antihypertensive drugs, лерканидипин, RM1-950, антагонисты кальция, артериальная гипертония, combined therapy, ace inhibitors, calcium antagonists, RC666-701, Diseases of the circulatory (Cardiovascular) system, эналаприл, Therapeutics. Pharmacology, фиксированные комбинации антигипертензивных препаратов, комбинированная терапия, enalapril, lercanidipine, ингибиторы АПФ
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
